GSK Sees Big Opportunity In OTC Diet Aids: Xenical Switch NDA Filed

GlaxoSmithKline filed an Rx-to-OTC switch application for Xenical (orlistat 60 mg) in June, the firm announced July 28

More from Archive

More from Pink Sheet